Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer's Disease.

Reich D, Gallucci G, Tong M, de la Monte SM.

J Parkinsons Dis Alzheimers Dis. 2018 May;5(1). doi: 10.13188/2376-922X.1000025. Epub 2018 May 21.

2.

Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β1-40 via activating the BDNF/TrkB signal pathway.

Zheng H, Niu S, Zhao H, Li S, Jiao J.

Metab Brain Dis. 2018 Dec;33(6):1961-1974. doi: 10.1007/s11011-018-0303-6. Epub 2018 Aug 13.

PMID:
30105614
3.

Confocal Synaptology: Synaptic Rearrangements in Neurodegenerative Disorders and upon Nervous System Injury.

Vulovic M, Divac N, Jakovcevski I.

Front Neuroanat. 2018 Feb 15;12:11. doi: 10.3389/fnana.2018.00011. eCollection 2018. Review.

4.

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages.

Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, Katsel P, Mechawar N, Haroutunian V, Epelbaum J, Daumas S, El Mestikawy S.

Sci Rep. 2018 Jan 17;8(1):938. doi: 10.1038/s41598-018-19154-y.

5.

Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats.

Wang Y, Tian Q, Liu EJ, Zhao L, Song J, Liu XA, Ren QG, Jiang X, Zeng J, Yang YT, Wang JZ.

J Cell Mol Med. 2017 Dec;21(12):3515-3528. doi: 10.1111/jcmm.13262. Epub 2017 Jun 28.

6.

Protective Effects of Fucoidan on Aβ25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice.

Wei H, Gao Z, Zheng L, Zhang C, Liu Z, Yang Y, Teng H, Hou L, Yin Y, Zou X.

Mar Drugs. 2017 Mar 16;15(3). pii: E77. doi: 10.3390/md15030077.

7.

Effect of Chaenomeles sinensis Extract on Choline Acetyltransferase Activity and Trimethyltin-Induced Learning and Memory Impairment in Mice.

Kwon YK, Choi SJ, Kim CR, Kim JK, Kim HK, Choi JH, Song SW, Kim CJ, Park GG, Park CS, Shin DH.

Chem Pharm Bull (Tokyo). 2015;63(12):1076-80. doi: 10.1248/cpb.c15-00559.

8.

Protective effects of luteolin against cognitive impairment induced by infusion of Aβ peptide in rats.

Yu TX, Zhang P, Guan Y, Wang M, Zhen MQ.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6740-7. eCollection 2015.

9.

Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1ΔE9 mice and its immunomodulatory mechanisms.

Gao L, Chen X, Tang Y, Zhao J, Li Q, Fan X, Xu H, Yin ZQ.

Exp Eye Res. 2015 Jun;135:47-58. doi: 10.1016/j.exer.2015.04.013. Epub 2015 Apr 23.

PMID:
25912193
10.
11.

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.

Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, Nordberg A, Wahlberg L, Darreh-Shori T, Eriksdotter M.

Alzheimers Dement. 2015 Nov;11(11):1316-28. doi: 10.1016/j.jalz.2014.11.008. Epub 2015 Feb 9.

PMID:
25676388
12.

Catalpol regulates cholinergic nerve system function through effect on choline acetyl-transferase not M receptor affinity.

Wang JH, Xie H, Zhao TK, Kang B.

Biomed Pharmacother. 2015 Feb;69:291-6. doi: 10.1016/j.biopha.2014.12.014. Epub 2014 Dec 19.

PMID:
25661372
13.

[Effects of beta-amyloid and apolipoprotein E4 on hippocampal choline acetyl transferase in rats].

Cui LX, Guo F, Li XY.

Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):325-9. doi: 10.3760/cma.j.issn.0529-5807.2013.05.008. Chinese.

PMID:
24004590
14.

Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats.

Javed H, Khan A, Vaibhav K, Moshahid Khan M, Ahmad A, Ejaz Ahmad M, Ahmad A, Tabassum R, Islam F, Safhi MM, Islam F.

Neurol Sci. 2013 Dec;34(12):2181-92. doi: 10.1007/s10072-013-1444-3. Epub 2013 May 17.

PMID:
23681104
15.

Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.

Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22. Review. English, Spanish.

16.

Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.

Ejaz Ahmed M, Khan MM, Javed H, Vaibhav K, Khan A, Tabassum R, Ashafaq M, Islam F, Safhi MM, Islam F.

Neurochem Int. 2013 Mar;62(4):492-501. doi: 10.1016/j.neuint.2013.02.006. Epub 2013 Feb 11.

PMID:
23411413
17.

Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.

Kerbler GM, Hamlin AS, Pannek K, Kurniawan ND, Keller MD, Rose SE, Coulson EJ.

Neuroimage. 2013 Feb 1;66:133-41. doi: 10.1016/j.neuroimage.2012.10.075. Epub 2012 Nov 2.

PMID:
23128077
18.

High-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in neuronal cultures for mechanistic and drug discovery studies.

Ray B, Bailey JA, Simon JR, Lahiri DK.

Curr Protoc Neurosci. 2012 Jul;Chapter 7:Unit 7.23. doi: 10.1002/0471142301.ns0723s60.

19.

Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats.

Colom LV, Castaneda MT, Hernandez S, Perry G, Jaime S, Touhami A.

Curr Alzheimer Res. 2011 Dec;8(8):832-40.

PMID:
22044024
20.

Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder.

Dugger BN, Murray ME, Boeve BF, Parisi JE, Benarroch EE, Ferman TJ, Dickson DW.

Neuropathol Appl Neurobiol. 2012 Apr;38(2):142-52. doi: 10.1111/j.1365-2990.2011.01203.x.

Supplemental Content

Loading ...
Support Center